Purpose
Intravitreal injection (IVI) is a common vitreoretinal procedure, and most of the patients, over the course of their disease, have to multiple IVI. Pain sensations during IVI may reduce the desire to continue the repeated IVI and cause sudden movements of the eye that to occur complications. The aim of this study to compare the effect of needle size on immediate intraocular pressure (IOP), vitreous reflux and patients’ pain experienced after the IVI.
Methods
A hundreds and ten eyes of 110 patients who were firstly administered intravitreal ranibizumab or aflibercept were randomized according to the use of needle size, 30-gauge (Group 1) or 26-gauge (Group 2). The reflux was graded post-IVI procedure. Immediately after the IVI, patients were administered to visual analogue scale (VAS) to assess the pain degree. The IOP measurements were taken 30 minutes after the operation. The average of these scores was used as the primary outcome.
Results
Both groups consisted of 55 patients were included the study. The mean VAS score was 2.18 in group 1 and 4 in the group 2. The reflux grade of the group 1 was also lesser than that of the group 2. IOP was comparable between the groups (26.3 ± 5.66 / 25.4 ± 4.02 mmHg). Groups were divided into subgroups according to the intravitreal agent use, there was not a statistically significant difference in the VAS scores.
Conclusions
Thirty-gauge needle is more comfortable and safer than 26-gauge needle for the IVI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.